Cargando…
The cytoprotective role of GM1 ganglioside in Huntington disease cells
BACKGROUND: Huntington disease (HD) is a neurodegenerative disease where a genetic mutation leads to excessive polyglutamine (Q) repeats in the huntingtin protein. The polyglutamine repeats create toxic plaques when the protein is cleaved, leading to neuron death. The glycolipid GM1 ganglioside (GM1...
Autores principales: | Hart, Hannah S., Valentin, Madeline A., Peters, Stephanie Toering, Holler, Susan W., Wang, Hongmin, Harmon, Aaron F., Holler, Larry D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712292/ https://www.ncbi.nlm.nih.gov/pubmed/36180805 http://dx.doi.org/10.1007/s11033-022-07830-2 |
Ejemplares similares
-
Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
por: Alpaugh, Melanie, et al.
Publicado: (2017) -
Reduced expression of gangliosides with GM2-determinant in cervical carcinoma-derived cells after subcutaneous transplantation into nude mice
por: Tanaka, Kyoko, et al.
Publicado: (2023) -
GM(1) Ganglioside Inhibits β‐Amyloid Oligomerization Induced by Sphingomyelin
por: Amaro, Mariana, et al.
Publicado: (2016) -
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019) -
The role of radiotherapy in the updated German S2k guideline for management of Merkel cell carcinoma
por: Vordermark, Dirk, et al.
Publicado: (2023)